Darcy B. Toms
Keine laufenden Positionen mehr
Profil
Darcy B.
Toms worked as a Principal at Aventis, Inc., Biovail Pharmaceuticals LLC, and as Vice President-Business Development at Valeritas, Inc. Toms holds an MBA from McGill University and an undergraduate degree from the University of Manitoba.
Ehemalige bekannte Positionen von Darcy B. Toms
| Unternehmen | Position | Ende |
|---|---|---|
| Aventis, Inc. | Corporate Officer/Principal | - |
| VALERITAS INC | Corporate Officer/Principal | - |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Ausbildung von Darcy B. Toms
| University of Manitoba | Undergraduate Degree |
| McGill University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Biovail Pharmaceuticals LLC
Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Health Technology |
| Aventis, Inc. | |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
